U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06890546) titled 'Nigella Sativa Supplementation in Hyperlipidemia Treatment' on March 09.
Brief Summary: Hyperlipidemia is defined as an elevation of plasma cholesterol, lipid, or lipoprotein levels above normal due to abnormal fat metabolism or function, and individuals with hyperlipidemia are approximately twice as likely to develop cardiovascular disease. The first approach to treating hyperlipidemia is lifestyle changes, including dietary therapy and physical activity. In addition to traditional methods, treatments also include pharmacological interventions, and research on natural products and complementary therapies is increasing to increase ...